Chief Investigator @darknatter.bsky.social shares insights from the #ADAPTsepsistrial at #CCRdownunder
@adaptsepsis @jama.com
@adaptsepsis @jama.com
December 10, 2024 at 3:19 AM
Chief Investigator @darknatter.bsky.social shares insights from the #ADAPTsepsistrial at #CCRdownunder
@adaptsepsis @jama.com
@adaptsepsis @jama.com
A major take home from ADAPT-SEPSIS - docs aren’t as good at stopping antibiotics as we think we are… #ccrdownunder
December 9, 2024 at 10:44 PM
A major take home from ADAPT-SEPSIS - docs aren’t as good at stopping antibiotics as we think we are… #ccrdownunder
Some images of today's sessions from #CCRdownunder
December 10, 2024 at 6:39 AM
Some images of today's sessions from #CCRdownunder
Less than 3 hours to #CCRdownunder in Melbourne
➡️ 8 major trial results over 2 days
➡️ In depth discussions
➡️ Full, free livestream
criticalcarereviews.com
➡️ 8 major trial results over 2 days
➡️ In depth discussions
➡️ Full, free livestream
criticalcarereviews.com
December 9, 2024 at 7:19 PM
Less than 3 hours to #CCRdownunder in Melbourne
➡️ 8 major trial results over 2 days
➡️ In depth discussions
➡️ Full, free livestream
criticalcarereviews.com
➡️ 8 major trial results over 2 days
➡️ In depth discussions
➡️ Full, free livestream
criticalcarereviews.com
Another albumin trial failing to show benefit. A recurring theme across different settings?
#CCRdownunder
#CCRdownunder
December 10, 2024 at 3:19 AM
Another albumin trial failing to show benefit. A recurring theme across different settings?
#CCRdownunder
#CCRdownunder
Looking forward to this one #RENOVATEtrial #CCRdownunder
December 11, 2024 at 12:01 AM
Looking forward to this one #RENOVATEtrial #CCRdownunder
Co-Chief Investigators Mark Dennis and Brian Burns share the findings from the #EVIDENCEtrial at #CCRdownunder
December 11, 2024 at 5:55 AM
Co-Chief Investigators Mark Dennis and Brian Burns share the findings from the #EVIDENCEtrial at #CCRdownunder
Published in JAMA with #CCRdownunder:
In critically ill adults with suspected sepsis, antibiotic regimens were safely reduced when guided by measurement of procalcitonin but not by C-reactive protein. @criticalcarereviews.com
ja.ma/3BovM5v
In critically ill adults with suspected sepsis, antibiotic regimens were safely reduced when guided by measurement of procalcitonin but not by C-reactive protein. @criticalcarereviews.com
ja.ma/3BovM5v
December 9, 2024 at 10:20 PM
Published in JAMA with #CCRdownunder:
In critically ill adults with suspected sepsis, antibiotic regimens were safely reduced when guided by measurement of procalcitonin but not by C-reactive protein. @criticalcarereviews.com
ja.ma/3BovM5v
In critically ill adults with suspected sepsis, antibiotic regimens were safely reduced when guided by measurement of procalcitonin but not by C-reactive protein. @criticalcarereviews.com
ja.ma/3BovM5v
RSI trial now starting
➡️ Etomidate vs Ketamine for RSI
➡️ Jonathan Casey & Matthew Semler presenting
➡️ Chris Nickson editorialising
➡️ Join the livestream - criticalcarereviews.com
#ccrdownunder
➡️ Etomidate vs Ketamine for RSI
➡️ Jonathan Casey & Matthew Semler presenting
➡️ Chris Nickson editorialising
➡️ Join the livestream - criticalcarereviews.com
#ccrdownunder
December 10, 2025 at 12:14 AM
RSI trial now starting
➡️ Etomidate vs Ketamine for RSI
➡️ Jonathan Casey & Matthew Semler presenting
➡️ Chris Nickson editorialising
➡️ Join the livestream - criticalcarereviews.com
#ccrdownunder
➡️ Etomidate vs Ketamine for RSI
➡️ Jonathan Casey & Matthew Semler presenting
➡️ Chris Nickson editorialising
➡️ Join the livestream - criticalcarereviews.com
#ccrdownunder
Congratulations to the RSI trial team #CCRdownunder
In a randomized trial involving critically ill patients undergoing intubation in EDs or ICUs, the use of ketamine for the induction of anesthesia did not lead to significantly lower in-hospital mortality than etomidate. Full trial results: nej.md/44EOlxB
@criticalcarereviews.com
@criticalcarereviews.com
December 10, 2025 at 12:34 AM
Congratulations to the RSI trial team #CCRdownunder
The stepped wedge design came up in the #CCRDownUnder meeting last week so it seemed a good time to revisit the pros and cons of this design 1/6
#MethodologyMonday #128
#MethodologyMonday #128
December 15, 2025 at 8:05 AM
The stepped wedge design came up in the #CCRDownUnder meeting last week so it seemed a good time to revisit the pros and cons of this design 1/6
#MethodologyMonday #128
#MethodologyMonday #128
#CCRdownunder attendees, check out these findings from this year's @criticalcarereviews.com meeting 🧵:
In critically ill adults w/ suspected sepsis, antibiotic regimens were reduced when guided by measurement of procalcitonin but not by C-reactive protein. ja.ma/49BSvrC
In critically ill adults w/ suspected sepsis, antibiotic regimens were reduced when guided by measurement of procalcitonin but not by C-reactive protein. ja.ma/49BSvrC
December 11, 2024 at 6:24 AM
#CCRdownunder attendees, check out these findings from this year's @criticalcarereviews.com meeting 🧵:
In critically ill adults w/ suspected sepsis, antibiotic regimens were reduced when guided by measurement of procalcitonin but not by C-reactive protein. ja.ma/49BSvrC
In critically ill adults w/ suspected sepsis, antibiotic regimens were reduced when guided by measurement of procalcitonin but not by C-reactive protein. ja.ma/49BSvrC
December 10, 2024 at 5:59 AM
All set for inaugural #ccrdownunder
4 major trial results coming up…
4 major trial results coming up…
December 9, 2024 at 9:28 PM
All set for inaugural #ccrdownunder
4 major trial results coming up…
4 major trial results coming up…
Chief Investigator Shane English and Senior Investigator Anthony Delaney share their findings from the #SAHaRAtrial at #CCRdownunder
December 10, 2024 at 7:56 AM
Chief Investigator Shane English and Senior Investigator Anthony Delaney share their findings from the #SAHaRAtrial at #CCRdownunder
High-flow nasal oxygen was noninferior to noninvasive ventilation for rates of endotracheal intubation or death within 7 days in 4 of the 5 patient groups with acute respiratory failure.
#CCRdownunder @criticalcarereviews.com
ja.ma/41s0Lbx
#CCRdownunder @criticalcarereviews.com
ja.ma/41s0Lbx
December 11, 2024 at 12:20 AM
High-flow nasal oxygen was noninferior to noninvasive ventilation for rates of endotracheal intubation or death within 7 days in 4 of the 5 patient groups with acute respiratory failure.
#CCRdownunder @criticalcarereviews.com
ja.ma/41s0Lbx
#CCRdownunder @criticalcarereviews.com
ja.ma/41s0Lbx
Chief Investigator Manu Shankar-Hari shares the findings from the #VACIRiSStrial at #CCRdownunder
December 10, 2024 at 5:27 AM
Chief Investigator Manu Shankar-Hari shares the findings from the #VACIRiSStrial at #CCRdownunder
Co-Chief Investigators Brenda O'Neill and Danny McAuley share the results of the #iRehab trial after presenting at #CCRdownunder
Livestream -> www.criticalcarereviews.com
@jama.com
Livestream -> www.criticalcarereviews.com
@jama.com
December 9, 2025 at 7:17 AM
Co-Chief Investigators Brenda O'Neill and Danny McAuley share the results of the #iRehab trial after presenting at #CCRdownunder
Livestream -> www.criticalcarereviews.com
@jama.com
Livestream -> www.criticalcarereviews.com
@jama.com
December 10, 2024 at 5:03 AM
Presented at #CCRDownUnder:
In the SAHARA trial involving patients with subarachnoid hemorrhage and anemia, liberal transfusion of red cells did not result in a lower risk of an unfavorable neurologic outcome than a more restrictive strategy. nej.md/4ilTVdO
In the SAHARA trial involving patients with subarachnoid hemorrhage and anemia, liberal transfusion of red cells did not result in a lower risk of an unfavorable neurologic outcome than a more restrictive strategy. nej.md/4ilTVdO
December 10, 2024 at 12:39 PM
Presented at #CCRDownUnder:
In the SAHARA trial involving patients with subarachnoid hemorrhage and anemia, liberal transfusion of red cells did not result in a lower risk of an unfavorable neurologic outcome than a more restrictive strategy. nej.md/4ilTVdO
In the SAHARA trial involving patients with subarachnoid hemorrhage and anemia, liberal transfusion of red cells did not result in a lower risk of an unfavorable neurologic outcome than a more restrictive strategy. nej.md/4ilTVdO
December 10, 2024 at 12:30 AM
RENOVATE trial
HFNC therapy versus non-invasive positive pressure ventilation in acute respiratory failure
Prof Israel Maia presents the results from CCR Down Under in Melbourne.
#CCRdownunder
HFNC therapy versus non-invasive positive pressure ventilation in acute respiratory failure
Prof Israel Maia presents the results from CCR Down Under in Melbourne.
#CCRdownunder
December 11, 2024 at 12:24 AM
RENOVATE trial
HFNC therapy versus non-invasive positive pressure ventilation in acute respiratory failure
Prof Israel Maia presents the results from CCR Down Under in Melbourne.
#CCRdownunder
HFNC therapy versus non-invasive positive pressure ventilation in acute respiratory failure
Prof Israel Maia presents the results from CCR Down Under in Melbourne.
#CCRdownunder